Post-transcriptional microRNA repression of PMP22 dose in severe Charcot-Marie-Tooth disease type 1

Abstract Copy number variation (CNV) may lead to pathological traits, and Charcot-Marie-Tooth disease type 1A (CMT1A), the commonest inherited peripheral neuropathy, is due to a genomic duplication encompassing the dosage-sensitive PMP22 gene. MicroRNAs act as repressors on post-transcriptional regu...

Full description

Saved in:
Bibliographic Details
Published in:Brain (London, England : 1878) England : 1878), 2023-10, Vol.146 (10), p.4025-4032
Main Authors: Pipis, Menelaos, Won, Seongsik, Poh, Roy, Efthymiou, Stephanie, Polke, James M, Skorupinska, Mariola, Blake, Julian, Rossor, Alexander M, Moran, John J, Munot, Pinki, Muntoni, Francesco, Laura, Matilde, Svaren, John, Reilly, Mary M
Format: Article
Language:English
Subjects:
Charcot-Marie-Tooth Disease - pathology
DNA Copy Number Variations
Gene Expression
Humans
MicroRNAs - genetics
Myelin Proteins - genetics
Myelin Proteins - metabolism
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Abstract Copy number variation (CNV) may lead to pathological traits, and Charcot-Marie-Tooth disease type 1A (CMT1A), the commonest inherited peripheral neuropathy, is due to a genomic duplication encompassing the dosage-sensitive PMP22 gene. MicroRNAs act as repressors on post-transcriptional regulation of gene expression and in rodent models of CMT1A, overexpression of one such microRNA (miR-29a) has been shown to reduce the PMP22 transcript and protein level. Here we present genomic and functional evidence, for the first time in a human CNV-associated phenotype, of the 3′ untranslated region (3′-UTR)-mediated role of microRNA repression on gene expression. The proband of the family presented with an early-onset, severe sensorimotor demyelinating neuropathy and harboured a novel de novo deletion in the PMP22 3′-UTR. The deletion is predicted to include the miR-29a seed binding site and transcript analysis of dermal myelinated nerve fibres using a novel platform, revealed a marked increase in PMP22 transcript levels. Functional evidence from Schwann cell lines harbouring the wild-type and mutant 3′-UTR showed significantly increased reporter assay activity in the latter, which was not ameliorated by overexpression of a miR-29a mimic. This shows the importance of miR-29a in regulating PMP22 expression and opens an avenue for therapeutic drug development. CMT1A is the commonest form of inherited neuropathy, presenting early in life with slowly progressive distal weakness and sensory loss, and is caused by duplication of the PMP22 gene. Pipis et al. indirectly show that the microRNA miR-29a represses PMP22 expression, and that loss of this effect can lead to more severe disease.
ISSN:0006-8950
1460-2156
DOI:10.1093/brain/awad203